Interchange Capital Partners’s Medicus Pharma MDCX Stock Holding History

Interchange Capital Partners’s Portfolio MDCX Stock Details MDCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$718K	Sell	1,586,871 -75,000	-5%	-$26.6K	0.14%	154
2026 Q1	$6.18M	Buy	1,661,871 +75,000	+5%	+$78.3K	1.95%	8
2025 Q4	$2.43M	Hold	1,586,871	–	–	0.45%	38
2025 Q3	$3.67M	Hold	1,586,871	–	–	0.72%	25
2025 Q2	$4.74M	Sell	1,586,871 -75,000	-5%	-$300K	1.1%	16
2025 Q1	$6.18M	Buy	1,661,871 +204,706	+14%	+$643K	1.73%	9
2024 Q4	$3.63M	Buy	+1,457,165	New	+$3.7M	1.31%	15

Other funds holding MDCX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MHC

May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WSFS

Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Interchange Capital Partners's MDCX Position: Q2 2026 in Review

Interchange Capital Partners reduced its Medicus Pharma (MDCX) stake by 4.5% in Q2 2026, selling an estimated $26.6K and leaving 1,586,871 shares worth $718K. The position accounts for 0.14% of the portfolio, ranked #154.

Interchange Capital Partners first reported a position in MDCX in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.18M in Q1 2026. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

Interchange Capital Partners held 1,586,871 shares of Medicus Pharma worth $718K as of Q2 2026.
Interchange Capital Partners sold 75,000 Medicus Pharma shares in Q2 2026, an estimated $26.6K.
Medicus Pharma made up 0.14% of Interchange Capital Partners's portfolio in Q2 2026, its #154 holding.
Interchange Capital Partners first reported a position in Medicus Pharma in Q4 2024 and has held it in 7 quarters since.
Interchange Capital Partners's Medicus Pharma position peaked at $6.18M in Q1 2026.
23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.